Tissue matrix metalloproteinases participate in extracellular matrix remodelling and degradation. Increased expression of MMP-9 and its inhibitor TIMP-1 are linked to unfavourable cardiovascular conditions, including inflammatory damage leading to increased plaque instability (1) . Vitamin D insufficiency is associated with higher MMP-9 concentrations, while vitamin D supplementation has been shown to decrease circulating MMP-9 and TIMP-1 concentrations in vitamin D-deficient adults (2) . The effect of vitamin D supplementation (0, 5, 10 and 15 mg cholecalciferol/d) on MMP-9 and TIMP-1 concentrations was investigated in two randomised placebo-controlled double-blind 22-week intervention studies in men and women aged 20-40 years (n 215; during winter 2006-7 (3) ) and ‡ 64 years (n 215; during winter 2007-8 (4) ) from Cork and Coleraine. Fasting serum levels of MMP-9, TIMP-1 and 25-hydroxyvitamin D (25(OH)D) were measured by ELISA at baseline and end point. BL, baseline; EP, end point (EP). Means in a row with unlike superscript letters were significantly different (P < 0.001).
Tissue matrix metalloproteinases participate in extracellular matrix remodelling and degradation. Increased expression of MMP-9 and its inhibitor TIMP-1 are linked to unfavourable cardiovascular conditions, including inflammatory damage leading to increased plaque instability (1) . Vitamin D insufficiency is associated with higher MMP-9 concentrations, while vitamin D supplementation has been shown to decrease circulating MMP-9 and TIMP-1 concentrations in vitamin D-deficient adults (2) . The effect of vitamin D supplementation (0, 5, 10 and 15 mg cholecalciferol/d) on MMP-9 and TIMP-1 concentrations was investigated in two randomised placebo-controlled double-blind 22-week intervention studies in men and women aged 20-40 years (n 215; during winter 2006-7 (3) ) and ‡ 64 years (n 215; during winter 2007-8 (4) ) from Cork and Coleraine. Fasting serum levels of MMP-9, TIMP-1 and 25-hydroxyvitamin D (25(OH)D) were measured by ELISA at baseline and end point. (4) BL, baseline; EP, end point (EP). Means in a row with unlike superscript letters were significantly different (P < 0.001).
ANOVA showed no baseline differences in the circulating concentrations of MMP-9, TIMP-1 or 25(OH)D between the four treatment groups. Baseline MMP-9 and TIMP-1 concentrations were significantly higher in adults aged 20-40 years (P < 0.001) and adults aged ‡ 64 years (P < 0.01) in Coleraine than in Cork. Linear regression analysis showed study centre to be the main predictor of MMP-9 (adjusted R 2 0.474; P < 0.001) and TIMP-1 (adjusted R 2 0.326; P < 0.001) concentrations in adults aged 20-40 years. In both age-groups pre-and post-intervention 25(OH)D concentrations were not associated with levels of MMP-9, TIMP-1 or MMP-9:TIMP-1. In both agegroups repeated measures analysis revealed no significant effect of the intervention on MMP-9 and TIMP-1 concentrations across the four groups, adjusting for centre, age, gender and BMI.
In conclusion, vitamin D supplementation had no effect on circulating MMP-9 and TIMP-1 concentrations in apparently-healthy adults aged 20-40 and ‡ 64 years.
